Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...
[12] In the current study, we confirmed positive cardiac remodeling over the long term using both TTE and CMR in patients with OSA receiving CPAP therapy. Our study demonstrates a reduction in RA ...